Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
European Journal of Cancer2019Vol. 124, pp. 110–122
Citations Over TimeTop 10% of 2019 papers
Ching‐Yao Yang, Wei‐Yu Liao, Chao‐Chi Ho, Kuan‐Yu Chen, Tzu‐Hsiu Tsai, Chia‐Lin Hsu, Kang‐Yi Su, Yih‐Leong Chang, Chen‐Tu Wu, Chia‐Chi Hsu, Bin-Chi Liao, Wei‐Hsun Hsu, Jih‐Hsiang Lee, Chia‐Chi Lin, Jin‐Yuan Shih, James Chih‐Hsin Yang, Chong‐Jen Yu
Related Papers
- → Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma(2005)164 cited
- → High Expression of ErbB Family Members and Their Ligands in Lung Adenocarcinomas That Are Sensitive to Inhibition of Epidermal Growth Factor Receptor(2005)144 cited
- → Expression of Epidermal Growth Factor (EGF) and Epidermal Growth Factor Receptor (EGFR) in Gastric and Colorectal Carcinomas1(1993)54 cited
- → Different Epidermal Growth Factor Receptor Gene Mutations in a Patient with 2 Synchronous Lung Cancers(2007)10 cited
- → Data from High Expression of ErbB Family Members and Their Ligands in Lung Adenocarcinomas That Are Sensitive to Inhibition of Epidermal Growth Factor Receptor(2023)